Skip to main content
logo
LTR Pharma Limited (ASX:LTP)
Australia flag Australia · Delayed Price · Currency is AUD
0.4650
0.00 (0.00%)
Last updated: Sep 11, 2026, 11:28 AM AEST

LTR Pharma Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
19.6631.813.11.731.91
Cash & Short-Term Investments
19.6631.813.11.731.91
Cash Growth
-38.19%925.31%79.46%-9.56%1205.48%
Accounts Receivable
0.030---
Other Receivables
0.220.080.270.060.04
Receivables
0.270.080.270.060.04
Inventory
0.570.02---
Prepaid Expenses
0.170.16---
Total Current Assets
20.6732.073.371.791.95
Property, Plant & Equipment
0.010.010--
Long-Term Investments
0.170.12---
Total Assets
20.8532.213.372.092.25

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
0.230.110.240.010.47
Accrued Expenses
0.290.50.130.010.01
Other Current Liabilities
0.080.10.06--
Total Current Liabilities
0.60.70.430.020.48
Total Liabilities
0.60.70.430.020.48

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
44.1144.1110.744.532.79
Retained Earnings
-29.24-15.07-9.48-2.52-1.07
Comprehensive Income & Other
5.372.471.670.070.04
Shareholders' Equity
20.2531.512.942.071.77
Total Liabilities & Equity
20.8532.213.372.092.25

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
19.6631.813.11.731.91
Net Cash Growth
-38.19%925.31%79.46%-9.56%-
Net Cash Per Share
0.110.190.020.01-
Filing Date Shares Outstanding
181.78180.98153.8414.9-
Total Common Shares Outstanding
181.78180.98139.42414.9-
Working Capital
20.0731.372.941.771.48
Book Value Per Share
0.110.170.020.00-
Tangible Book Value
20.2531.512.942.071.77
Tangible Book Value Per Share
0.110.170.020.00-